What’s New2018-09-12T05:37:15+00:00

September Highlights

Personalis news and events

Personalis Presents

Join us as we present at upcoming conferences:

  • Rational Combinations 360°, Philadelphia | Sep 13-14
  • Advances in Immuno-oncology USA, San Diego | Oct 11-12
  • World Immunotherapy Congress, Switzerland | Oct 29-31
  • Neoantigen Summit 2018, Boston | Nov 14-16
  • ICI Europe 2018, Berlin | Nov 28-29
Learn More

Solutions for
Personalized Cancer Vaccines

New Xtalks webinar

Neoantigens for Personalized Cancer Vaccines: Comprehensive identification and effective selection.

Watch Now

Solutions for
Biomarker Discovery

Xtalks webinar

Overcoming the challenges of Immuno-Oncology Biomarker Discovery: From Sample to Analytics

Watch Now

Solutions for
Personalized Cancer Vaccines

In the news

Personalis, Inc. receives approval from the NY State Department of Health for use of its ACE InnumoID™ platform in the cancer immunotherapeutic clinical trials.

View Now

Solutions for
Biomarker Discovery

ACE ImmunoID

Precision Immunogenomics

A universal biomarker platform for immuno-oncology

Download PDF

Solutions for
Personalized Cancer Vaccines

Neoantigen workflow

Generates NeoantigenID analytics

Learn More

Solutions for
Biomarker Discovery

Biomarker Discovery

ACE ImmunoID Platform for Tumor Immunogenomics

When one biomarker doesn’t tell the whole story

Download PDF

Solutions for
Personalized Cancer Vaccines

Genomics Solutions for Neoantigen Vaccines

High-quality, comprehensive genomic data and analytics

Download PDF

Solutions for
Biomarker Discovery

Read our blog!

Comparing and contrasting CTLA-4 and PD-L1/PD-1: A tale of two immune checkpoint inhibitors

Read Now

Solutions for
Personalized Cancer Vaccines

Presentation at
Rational Combinations 360° 

Demystifying tumor immunogenomics: Key challenges and solutions

Join Us